181 related articles for article (PubMed ID: 21502079)
1. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.
Simmons R; Sharp C; Sims S; Kloverpris H; Goulder P; Simmonds P; Bowness P; Klenerman P
J Infect Dis; 2011 May; 203(10):1378-87. PubMed ID: 21502079
[TBL] [Abstract][Full Text] [Related]
2. Evolution of CD8+ T cell responses after acute PARV4 infection.
Simmons R; Sharp C; Levine J; Bowness P; Simmonds P; Cox A; Klenerman P
J Virol; 2013 Mar; 87(6):3087-96. PubMed ID: 23283958
[TBL] [Abstract][Full Text] [Related]
3. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus 4 infection and clinical outcome in high-risk populations.
Simmons R; Sharp C; McClure CP; Rohrbach J; Kovari H; Frangou E; Simmonds P; Irving W; Rauch A; Bowness P; Klenerman P;
J Infect Dis; 2012 Jun; 205(12):1816-20. PubMed ID: 22492853
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus PARV4 visualization and detection.
Tuke PW; Parry RP; Appleton H
J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
8. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.
Abdelwahab SF; Zakaria Z; Sobhy M; Rewisha E; Mahmoud MA; Amer MA; Del Sorbo M; Capone S; Nicosia A; Folgori A; Hashem M; El-Kamary SS
Clin Vaccine Immunol; 2012 May; 19(5):780-6. PubMed ID: 22441392
[TBL] [Abstract][Full Text] [Related]
10. Persistence of novel human parvovirus PARV4 in liver tissue of adults.
Schneider B; Fryer JF; Reber U; Fischer HP; Tolba RH; Baylis SA; Eis-Hübinger AM
J Med Virol; 2008 Feb; 80(2):345-51. PubMed ID: 18098166
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
Manning A; Willey SJ; Bell JE; Simmonds P
J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
[TBL] [Abstract][Full Text] [Related]
13. T lymphocyte responses against human parvovirus B19: small virus, big response.
Klenerman P; Tolfvenstam T; Price DA; Nixon DF; Broliden K; Oxenius A
Pathol Biol (Paris); 2002 Jun; 50(5):317-25. PubMed ID: 12116850
[TBL] [Abstract][Full Text] [Related]
14. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
[TBL] [Abstract][Full Text] [Related]
15. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Maple PA; Beard S; Parry RP; Brown KE
Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
[TBL] [Abstract][Full Text] [Related]
16. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
[TBL] [Abstract][Full Text] [Related]
17. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
[TBL] [Abstract][Full Text] [Related]
18. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
[TBL] [Abstract][Full Text] [Related]
19. Impact of HIV on host-virus interactions during early hepatitis C virus infection.
Danta M; Semmo N; Fabris P; Brown D; Pybus OG; Sabin CA; Bhagani S; Emery VC; Dusheiko GM; Klenerman P
J Infect Dis; 2008 Jun; 197(11):1558-66. PubMed ID: 18419344
[TBL] [Abstract][Full Text] [Related]
20. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.
Chen MY; Hung CC; Lee KL
Virol J; 2015 Jun; 12():94. PubMed ID: 26088443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
